Rengalin

DRUG2 trials

Sponsors

Materia Medica Holding

Conditions

Chronic Obstructive Pulmonary DiseaseCough

Phase 3

Efficacy and Safety of Rengalin in the Treatment of ARVI Cough in Children

RecruitingNCT07171099

Materia Medica HoldingCough

Start: 2025-10-03End: 2028-12-31Target: 264Updated: 2026-02-13

Phase 4

Clinical Trial of Efficacy and Safety of Rengalin in the Treatment of Cough in Patients With Chronic Obstructive Pulmonary Disease

CompletedNCT03159091

Materia Medica HoldingChronic Obstructive Pulmonary Disease

Start: 2017-06-16End: 2019-04-25Updated: 2020-12-11

Related Papers

Management of Cough in Patients with Chronic Obstructive Pulmonary Disease: Results of the Multicenter Randomized Placebo-Controlled Clinical Trial

International Journal of COPD2021-05-018 citations